The pathophysiologic basis for the use of dobutamine echocardiography for the assessment of myocardial viability

Research output: Contribution to journalArticle

Abstract

Using clinical and electrocardiographic information alone, it is often difficult to determine whether dysfunctional myocardial segments are viable. Based on its ability to elicit contractile reserve, dobutamine has been found to be useful in assessing the presence or absence of viability in these segments. Imaging with two-dimensional echocardiography at rest and during different doses of dobutamine is currently used as a diagnostic tool for assessing viability both after acute myocardial infarction and in the context of chronic coronary artery disease. This review will discuss the pathophysiologic basis for the use of dobutamine echocardiography in these clinical settings.

Original languageEnglish (US)
Pages (from-to)149-154
Number of pages6
JournalCardiovascular Imaging
Volume8
Issue number1
StatePublished - 1996
Externally publishedYes

Fingerprint

Dobutamine
Echocardiography
Coronary Artery Disease
Myocardial Infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

@article{20b00cfa8c4445a7a847de37bc13e372,
title = "The pathophysiologic basis for the use of dobutamine echocardiography for the assessment of myocardial viability",
abstract = "Using clinical and electrocardiographic information alone, it is often difficult to determine whether dysfunctional myocardial segments are viable. Based on its ability to elicit contractile reserve, dobutamine has been found to be useful in assessing the presence or absence of viability in these segments. Imaging with two-dimensional echocardiography at rest and during different doses of dobutamine is currently used as a diagnostic tool for assessing viability both after acute myocardial infarction and in the context of chronic coronary artery disease. This review will discuss the pathophysiologic basis for the use of dobutamine echocardiography in these clinical settings.",
author = "Sanjiv Kaul",
year = "1996",
language = "English (US)",
volume = "8",
pages = "149--154",
journal = "Cardiovascular Imaging",
issn = "1120-0421",
publisher = "C E P I - Centro Editoriale Pubblicitario Italiano s.r.l.",
number = "1",

}

TY - JOUR

T1 - The pathophysiologic basis for the use of dobutamine echocardiography for the assessment of myocardial viability

AU - Kaul, Sanjiv

PY - 1996

Y1 - 1996

N2 - Using clinical and electrocardiographic information alone, it is often difficult to determine whether dysfunctional myocardial segments are viable. Based on its ability to elicit contractile reserve, dobutamine has been found to be useful in assessing the presence or absence of viability in these segments. Imaging with two-dimensional echocardiography at rest and during different doses of dobutamine is currently used as a diagnostic tool for assessing viability both after acute myocardial infarction and in the context of chronic coronary artery disease. This review will discuss the pathophysiologic basis for the use of dobutamine echocardiography in these clinical settings.

AB - Using clinical and electrocardiographic information alone, it is often difficult to determine whether dysfunctional myocardial segments are viable. Based on its ability to elicit contractile reserve, dobutamine has been found to be useful in assessing the presence or absence of viability in these segments. Imaging with two-dimensional echocardiography at rest and during different doses of dobutamine is currently used as a diagnostic tool for assessing viability both after acute myocardial infarction and in the context of chronic coronary artery disease. This review will discuss the pathophysiologic basis for the use of dobutamine echocardiography in these clinical settings.

UR - http://www.scopus.com/inward/record.url?scp=0029821910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029821910&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029821910

VL - 8

SP - 149

EP - 154

JO - Cardiovascular Imaging

JF - Cardiovascular Imaging

SN - 1120-0421

IS - 1

ER -